Sana Biotechnology

SANA

Sana Biotechnology (SANA)

Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines in the United States. It develops ex vivo and in vivo cell...

Open
--
High
--
Low
--
Prev. Close
--
Volume
--
Turnover
--
Avg Price
--
Bid/Ask Ratio
--
Amplitude
--
52wk High
--
Volume Ratio
--
Turnover Ratio
--
52wk Low
--
Float Mkt Cap
--
Market Cap
--
P/ETTM
--
P/EDynamic
--
P/EStatic
--
EPSTTM
--
EPSDynamic
--
EPSStatic
--
BVPS
--
P/B
--
Circulating Supply
--
Dividend YieldTTM
--
DividendTTM
--
Shares
--
Min lot size
--
Currency
--

Sana Biotechnology Analyst Rating

View more

Forecast & Rating

Aug 21, 2026
Price forecast
$8.43227.96%
Forecast & RatingStrong buy
9analysts
  • Strong buy66.67%
  • Buy22.22%
  • Hold11.11%
  • Sell0.00%
  • Strong sell0.00%

News

Bullish vs. Bearish — Last 3 Months

743 followers · 0 opinions
▲Bullish50%
50%Bearish▼
  • Y
    YOLO~Nvidia

    WSB Hot Discussion | SANA Soars 160.6%, QUBT Plummets 43.3%

    Sana Biotechnology, Inc. SANA (SANA) 24-hour price change: 160.6% (small-cap pharmaceutical stock, generally not participating) Sana Biotechnology (stock code: SANA) has recently seen a strong surge in its stock price, mainly due to breakthrough progress in its diabetes research, coupled with a dual benefit from TD Cowen raising its rating. The market generally views the company's "hardcore" strength in the field of cell engineering therapy positively, especially its innovative breakthroughs in "bottleneck" medical challenges such as hematological malignancies and diabetes. Analysts believe...